Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings-Reference-Cited by-同舟云学术

Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings

Published:2021-06 Issue:6 Volume:3 Page:703-713
ISSN:2589-790X
Container-title:CJC Open
language:en
Short-container-title:CJC Open

Author:

Quinn Amity E.,Ronksley Paul E.,Bresee Lauren,Au Flora,Wick James,Leung Alexander A.,McBrien Kerry A.,Manns Braden J.,Beall Reed F.

Funder

M.S.I. Foundation

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. Healthcare costs attributable to hypertension;Weaver;Hypertension,2015

2. Patra J, Popova S, Rehm J, et al. Economic cost of chronic disease in Canada. Ontario chronic disease prevention alliance and the Ontario public health association (2007). Available at: https://www.ocdpa.ca/sites/default/files/publications/OCDPA_EconomicCosts.pdf. Accessed April 12, 2021.

3. The effect of cost on adherence to prescription medications in Canada;Law;CMAJ,2012

4. Improving adherence to therapy and clinical outcomes while containing costs: opportunities from the greater use of generic medications: best practice advice from the clinical guidelines committee of the American College of Physicians;Choudhry;Ann Intern Med,2016

5. Medication non-adherence is associated with increased medical health care costs;Kane;Dig Dis Sci,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescription Trends of Thiazide Diuretics in a Canadian Primary Care Population From 2015 to 2021;CJC Open;2024-06

2. Prescribing cascades of antigout medications from thiazide diuretics in gout-naïve hypertensive adults receiving first-line pharmacological management;Scientific Reports;2024-03-28

3. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study;Journal of the American Academy of Dermatology;2023-08

4. Trends in antihypertensive drug utilization in British Columbia, 2004–2019: a descriptive study;CMAJ Open;2023-07

5. Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real‐world data analysis;The Journal of Clinical Hypertension;2022-09-20